Cross-platform delivery
Native mobile audio, browser-based clinician controls and focused client displays support in-person and remote workflows.
INVESTOR BRIEF
The connected layer for bilateral stimulation
Affect Forge brings clinician control, client-facing stimulation and sensor-informed research into one cross-platform system.
Product and wearable concept imagery · features in development
THE INVESTMENT THESIS
A focused platform for a complex clinical workflow
EMDR already operates within established PTSD care pathways. The opportunity is to improve the tools around delivery: synchronized bilateral cues, simple remote controls, accessible client reporting and carefully bounded physiological context.
Affect Forge begins with software clinicians can use today and develops the evidence, hardware and quality systems required for more advanced capabilities over time.
ONE CONTROL PLANE
Sound, light and touch in one session system
The platform separates the practitioner workspace from a focused client experience, then connects compatible devices through a shared session rhythm.
CLINICIANSession StudioControl, timing and observation
SOUNDNative bilateral audio
LIGHTClient and room displays
TOUCHConnected haptics
CONTEXTOptional pulse and EDA research
PLATFORM ADVANTAGE
Software first. Evidence led. Built to expand.
Connected hardware path
Haptic units and the Duo Ring concept extend the system while keeping the software layer useful on its own.
Research-ready foundation
Accessible reporting formats and physiological trends are treated as questions to validate, not automated clinical conclusions.
DUO RING CONCEPT · HARDWARE IN DEVELOPMENTTHE CLOSED-LOOP RESEARCH PATH
More context without replacing clinical judgement
The proposed sensor layer combines client report, practitioner observation and optional physiological trends. Future gaze-engagement research may add another measurable signal, processed on the client device.
- Privacy by designPrefer local processing and transmit only the minimum session data required.
- Accessible reportingInvestigate alternatives when standard numeric scales do not fit the client.
- Explicit boundariesNo single biometric signal identifies an emotion, diagnosis or treatment outcome.
CLINICAL AND ECONOMIC CONTEXT
An established treatment category with room for better tools
Public evidence supports EMDR as an option in adult PTSD care. The commercial thesis for Affect Forge remains a product hypothesis until prospective studies demonstrate workflow, safety and outcome benefits.
34%
Modelled probability of being most cost-effective
A 2020 English NHS model compared ten interventions and no treatment. EMDR had a 34% probability of being the most cost-effective option at £20,000 per QALY. [I2]
Published model, not an Affect Forge resultEMDR appears in national evidence and guidance
SBU reports evidence supporting EMDR for adult PTSD and describes Socialstyrelsen’s prioritization of EMDR in its 2017 national guidance. [I1] [I3]
Adaptation should remain individual
Published therapist consensus supports flexibility and clear communication when using EMDR with autistic people. [I4]
DE-RISKING THE VISION
A staged path from product to evidence
- NOW
Core platform
Strengthen cross-platform session control, native timing, privacy boundaries and clinician workflows.
- NEXT
Pilot integrations
Evaluate connected haptics, sensor quality and accessible reporting with clinicians and research partners.
- THEN
Prospective validation
Test usability, safety, measurement validity and health-economic assumptions before making outcome claims.
- SCALE
Regulated expansion
Define intended purpose and follow the appropriate conformity path if validated features enter medical-device scope. [I5]
GO-TO-MARKET FOCUS
Start with practitioners. Prove value with partners.
Private and specialist care
Early users provide direct workflow feedback and create a path to disciplined product iteration.
Research partnerships
University and clinical collaborators can test measurement quality, usability and defined study hypotheses.
Public procurement
Region-level adoption requires evidence, information-security review and credible implementation economics.
INVESTOR TRANSPARENCY
What is built, proposed and still to prove
- Available platform foundation
- Native mobile bilateral audio, web session controls, client displays and connected-device development.
- In development
- Wearable haptics, Duo Ring sensing concepts and broader cross-platform delivery.
- Research proposals
- Closed-loop biofeedback, gaze engagement, accessible scale alternatives and group-intervention workflows.
- Not claimed
- Medical-device certification, automated treatment decisions, validated clinical outcomes or guaranteed cost savings.
RESEARCH REFERENCES
Evidence behind the context
- I1
Psychological, psychosocial and other non-pharmacological treatments of PTSD in adults
Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU). Commentary on the NICE evidence review for adult PTSD treatment, 2019.
SBU reports evidence supporting EMDR for adult PTSD while noting that certainty across evaluated interventions was generally low.
View source - I2
Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults
Mavranezouli, I., et al. (2020). PLOS ONE, 15(4), e0232245. DOI: 10.1371/journal.pone.0232245.
In an English NHS model comparing 11 options, EMDR had a 34% probability of being the most cost-effective at a £20,000 per QALY threshold. This is modelled evidence, not an Affect Forge outcome.
View source - I3
National guidelines for depression and anxiety disorders
The Swedish National Board of Health and Welfare (Socialstyrelsen). National guidelines and evaluation materials.
The national guidance provides the Swedish care-policy context. It does not constitute approval of Affect Forge or any other specific software product.
View source - I4
Using EMDR with autistic individuals: A Delphi survey with EMDR therapists
Fisher, N., van Diest, C., Leoni, M., & Spain, D. (2023). Autism, 27(1), 43–53. DOI: 10.1177/13623613221080254.
The therapist-consensus study supports individualized adaptation and clearer communication. It does not validate a specific digital scale or biometric intervention.
View source - I5
Medical devices: new regulations
European Commission. Overview of Regulations (EU) 2017/745 and 2017/746.
Any future medical-device positioning depends on intended purpose, classification and conformity assessment. Affect Forge has not claimed certification on this page.
View source
Sources reviewed . This is a focused investor overview, not a systematic review.
BUILD THE EVIDENCE WITH US
Help shape a more connected standard for bilateral stimulation
We are opening conversations with aligned investors, clinical research partners and healthcare innovators.
Contact Affect Forge